Your browser doesn't support javascript.
loading
Recurrences of Pituitary Adenomas or Second De Novo Tumors: Comparisons with First Tumors.
Saeger, Wolfgang; Müller, Maximilian; Buslei, Rolf; Flitsch, Jörg; Fahlbusch, Rudolf; Buchfelder, Michael; Knappe, Ulrich J; Crock, Patricia A; Lüdecke, Dieter K.
Afiliación
  • Saeger W; Institute of Neuropathology, University of Hamburg, Hamburg, Germany. Electronic address: w.saeger@uke.de.
  • Müller M; Institute of Neuropathology, University of Hamburg, Hamburg, Germany.
  • Buslei R; Institute of Pathology, SozialStiftung Bamberg, Bamberg, Germany.
  • Flitsch J; Clinic of Neurosurgery, University of Hamburg, Hamburg, Germany.
  • Fahlbusch R; International Neuroscience Institute (INI), Hannover, Germany.
  • Buchfelder M; Clinic of Neurosurgery, Friedrich-Alexander University Erlangen-Nürnberg (FAU), Erlangen, Germany.
  • Knappe UJ; Department of Neurosurgery, Johannes-Wesling-Klinikum Minden, Minden, Germany.
  • Crock PA; Department of Paediatric Endocrinology, John Hunter Children's Hospital, University of Newcastle, Newcastle, Australia.
  • Lüdecke DK; Clinic of Neurosurgery, University of Hamburg, Hamburg, Germany.
World Neurosurg ; 119: e118-e124, 2018 Nov.
Article en En | MEDLINE | ID: mdl-30026158
BACKGROUND: Recurrences of pituitary adenomas are not so rare. METHODS: In the German Registry of Pituitary Tumors, more than 12,000 surgical specimens were collected between 1967 and 2012, of which 312 patients with altogether 334 recurrences (n = 646 specimens) were included in our study. RESULTS: The histopathology of 162 recurrent adenomas could be compared with the original tumor and 37 second recurrences could be compared with the first recurrence. Comparing the proliferation index (Ki-67) of the original and the first recurrent tumor (n = 162), we found an unchanged index in 43 cases (26%), whereas in 69 cases (43%) the index increased and in 50 cases (31%) it decreased. Comparing the first with the second recurrence (n = 37), we found an unchanged index in 8 cases (22%), an increased index in 15 cases (40%), and a decreased index in 14 cases (38%). The third recurrence showed an unchanged index in 1 case (20%), an increased index in 2 cases (40%), and a decreased index in 2 cases (40%). p53 was unchanged in recurrences in 44% of cases, increased in 33%, and decreased in 22%. In 4 cases, adenomas developed into adenomas with strongly increased proliferation (formerly atypical adenomas, now aggressive adenomas) for the first recurrence, and 9 recurrences became aggressive adenomas. A change of tumor type without change of the common transcription factor occurred in 82 cases. CONCLUSIONS: A second independent de novo adenoma was present in 10 cases, probably due to changes of transcription factors.
Asunto(s)
Palabras clave

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias Hipofisarias / Adenoma / Recurrencia Local de Neoplasia Tipo de estudio: Observational_studies Idioma: En Revista: World Neurosurg Asunto de la revista: NEUROCIRURGIA Año: 2018 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias Hipofisarias / Adenoma / Recurrencia Local de Neoplasia Tipo de estudio: Observational_studies Idioma: En Revista: World Neurosurg Asunto de la revista: NEUROCIRURGIA Año: 2018 Tipo del documento: Article